1910genetics is a pioneering biotechnology company that integrates artificial intelligence (AI), computational science, and biological automation to accelerate the discovery and development of novel therapeutics. The company focuses on creating both small molecule and protein-based drugs by employing its multimodal AI platforms, ELVIS™ and ROSALYND™, to overcome challenges in early-stage drug development. Their approach aims to significantly reduce timelines and improve the success rates of identifying promising drug candidates for a wide range of diseases.
The headquarters serves as the central hub for all company operations, including AI-driven research, drug discovery and development laboratories, computational biology, software engineering, and corporate administration.
The headquarters at 99 A Street features purpose-built, modern laboratory spaces for biological automation and experimentation, alongside collaborative office areas designed to support computational research and AI model development. Its location in the Seaport District provides access to a rich ecosystem of biotech peers and research institutions.
A dynamic and mission-driven work culture that fosters innovation through interdisciplinary collaboration between experts in AI, computational biology, chemistry, and drug development. Emphasis on scientific excellence, rapid iteration, and translating cutting-edge research into tangible therapeutic solutions.
Located in Boston's Seaport District, a leading global biotechnology cluster, the headquarters provides 1910genetics with strategic advantages including access to top-tier talent, proximity to world-class research institutions and hospitals, and a vibrant network for collaborations and partnerships.
While 1910genetics is primarily based at its Boston headquarters, its mission to develop novel therapeutics addresses global health needs. The company engages in research and collaborations that may have international components and aims for its discoveries to ultimately benefit patients worldwide. Their talent acquisition may also be global, attracting experts from various countries.
99 A Street
Boston
MA
USA
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, 1910 Genetics' leadership includes:
1910 Genetics has been backed by several prominent investors over the years, including:
In the last 12 months, 1910genetics has strategically expanded its executive leadership, notably with the appointment of a new Chief Business Officer. No significant executive departures have been publicly announced during this period, indicating stability and continued growth in its leadership team.
Discover the tools 1910 Genetics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
1910genetics likely utilizes standard corporate email formats for its employees. Common patterns include [first initial][last name]@[companydomain.com] or [first name].[last name]@[companydomain.com]. For example, jdoe@1910genetics.com or jane.doe@1910genetics.com.
[first_initial][last]@1910genetics.com
Format
jdoe@1910genetics.com
Example
75%
Success rate
PR Newswire • January 10, 2024
1910genetics announced the strategic appointment of Bridget Cole, Ph.D., as its new Chief Business Officer. Dr. Cole brings a wealth of experience in biopharmaceutical business development and corporate strategy, aiming to drive the company's partnering efforts and strategic growth initiatives in the AI-driven drug discovery space....more
Business Wire • March 2, 2023
1910 Genetics strengthened its leadership team with the appointment of Desmond Padhi, Ph.D., as Chief Scientific Officer. Dr. Padhi, with over two decades of experience in drug discovery and development from leading pharmaceutical companies, will guide the company's scientific vision and oversee its R&D pipeline....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including 1910 Genetics, are just a search away.